CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 191 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,000 | +7.4% | 1,146 | -60.0% | 0.00% | – |
| Q2 2022 | $68,000 | +6.2% | 2,862 | 0.0% | 0.00% | – |
| Q1 2022 | $64,000 | +12.3% | 2,862 | 0.0% | 0.00% | – |
| Q4 2021 | $57,000 | +1.8% | 2,862 | 0.0% | 0.00% | – |
| Q3 2021 | $56,000 | -11.1% | 2,862 | 0.0% | 0.00% | – |
| Q2 2021 | $63,000 | -7.4% | 2,862 | 0.0% | 0.00% | – |
| Q1 2021 | $68,000 | -29.2% | 2,862 | -22.1% | 0.00% | – |
| Q4 2020 | $96,000 | +50.0% | 3,676 | 0.0% | 0.00% | – |
| Q3 2020 | $64,000 | +3.2% | 3,676 | 0.0% | 0.00% | – |
| Q2 2020 | $62,000 | -62.4% | 3,676 | -73.6% | 0.00% | – |
| Q1 2020 | $165,000 | -1.8% | 13,900 | 0.0% | 0.00% | – |
| Q4 2019 | $168,000 | -53.1% | 13,900 | -45.1% | 0.00% | -100.0% |
| Q3 2019 | $358,000 | -57.7% | 25,300 | -66.7% | 0.00% | – |
| Q2 2019 | $846,000 | +171.2% | 75,900 | +338.7% | 0.00% | -100.0% |
| Q4 2017 | $312,000 | +127.7% | 17,300 | +143.7% | 0.00% | – |
| Q3 2017 | $137,000 | – | 7,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |